Local Injectable Steroids: Recommended Dosing and Administration

Dosing Guidelines by Condition

For nodular acne, the American Academy of Dermatology recommends triamcinolone acetonide 10 mg/mL, which may be diluted with sterile normal saline to 5 or 3.3 mg/mL 1, 2
For acne keloidalis, the American Academy of Dermatology recommends triamcinolone acetonide 10 mg/mL for inflammatory follicular lesions 1, 2
For hypertrophic scars and keloids, the American Academy of Dermatology recommends triamcinolone acetonide 40 mg/mL 1, 2
For psoriasis, the American Academy of Dermatology recommends triamcinolone acetonide up to 20 mg/mL every 3-4 weeks (injection volume varies based on lesion size) 3, 4
For esophageal strictures, the American Gastroenterological Association recommends 0.5 mL aliquots of triamcinolone 40 mg/mL injected into four quadrants immediately before bougie dilatation 5, 6

Administration Technique

For esophageal strictures, the American Gastroenterological Association recommends using a 4 mm-long, 23-gauge needle and leaving it in place for at least 1 minute to minimize leakage 6

Frequency of Administration

For most conditions, the American Academy of Dermatology recommends administration every 3-4 weeks as needed 3, 4
For acute gout, the American College of Rheumatology recommends a single injection often sufficient 7, 8
For esophageal strictures, the American Gastroenterological Association recommends administration as needed based on symptom recurrence (typically lasts up to 1 year) 6

Common Pitfalls and Precautions

The American Academy of Dermatology recommends avoiding injection at sites of active infection (impetigo, herpes) 1, 2
The American Academy of Dermatology recommends not using triamcinolone in patients with previous hypersensitivity to triamcinolone 1, 2
The American Academy of Dermatology recommends avoiding large injections in patients with active tuberculosis or systemic fungal infections 1, 2
The American Academy of Dermatology recommends being cautious in patients with uncontrolled diabetes, heart failure, or severe hypertension 1, 2
The American Academy of Dermatology recommends monitoring for local adverse effects including skin atrophy, pigmentary changes, telangiectasias, and hypertrichosis 1, 2, 4
The American Academy of Dermatology recommends being aware that repeated injections can suppress the hypothalamic-pituitary-adrenal axis 1, 2
The American Academy of Dermatology recommends being aware that facial and intertriginous areas are at higher risk for developing adverse effects 4

Special Considerations

For juvenile idiopathic arthritis, the American College of Rheumatology strongly recommends intra-articular glucocorticoid injections as part of initial therapy, with triamcinolone hexacetonide being the preferred agent 9
For gout, the American College of Rheumatology recommends intra-articular corticosteroids for acute attacks involving 1-2 large joints 8

Recommended Dosage of Triamcinolone for Shoulder Injection

Dosing Guidelines

For shoulder pain and hemiplegic shoulder pain, intra-articular injections of triamcinolone (40 mg) are commonly used and have shown significant effects on pain reduction 10
For subacromial or glenohumeral injections, 40 mg of triamcinolone acetonide is typically administered, though the evidence for long-term pain reduction is not well established 11

Administration Technique

Injections can be performed into either the glenohumeral joint or subacromial space depending on the underlying pathology 11

Common Pitfalls and Precautions

Be aware that the usefulness of subacromial or glenohumeral corticosteroid injection for shoulder inflammation is not well established according to some guidelines 11

Triamcinolone Dose for Steroid Injection in the Palm of Hand

Recommended Dosing Protocol

The American Academy of Dermatology recommends triamcinolone acetonide 5-10 mg/mL, with 0.05-0.1 mL per injection site producing localized therapeutic effect for smaller lesions or dermatologic conditions in the palm 12
Monitor for skin atrophy, a consistent side effect of intralesional corticosteroid therapy, particularly with triamcinolone 12

Safety of Low-Dose Triamcinolone for Local Injection

Guideline-Recommended Dosing Ranges

The British Association of Dermatologists recommends triamcinolone acetonide 5-10 mg/mL with injection volumes of 0.05-0.1mL per site, producing localized therapeutic effect, which translates to 0.25-1mg per injection site 13

Comparative Dosing Context

For alopecia areata, a concentration of 5-10 mg/mL is recommended, with multiple injection sites, as suggested by the British Association of Dermatologists 13

Safety Considerations at This Dose

Local adverse effects, such as skin atrophy, pigmentary changes, and telangiectasias, are dose-dependent and typically occur with repeated injections at higher concentrations or volumes, as noted by the British Association of Dermatologists 13

Kenalog Dosing Guidelines

Dermatologic Conditions

For nail psoriasis affecting the nail matrix, the American Academy of Dermatology recommends intralesional triamcinolone acetonide 5-10 mg/mL 14
For recurrent, severe, or treatment-refractory paronychia, intralesional triamcinolone acetonide is recommended, according to the Journal of the American Academy of Dermatology 14
The maximum dose per injection site should not exceed 150 mg, as stated by the Journal of Allergy and Clinical Immunology 15

Intralesional Injection Technique for Keloids

Administration Technique

Inject just beneath the dermis in the upper subcutis, as recommended by the British Association of Dermatologists, for effective treatment of keloids 16

Administration of Kenalog Injections

Concentration Selection and Injection Technique

For juvenile idiopathic arthritis, the American College of Rheumatology strongly prefers triamcinolone hexacetonide over triamcinolone acetonide for intra-articular injections due to more durable clinical responses 17
The Mayo Clinic recommends using a 4-mm needle for subcutaneous injections as it is the safest option for all patients regardless of age, sex, ethnicity, or BMI, with minimal risk of intramuscular injection 18
The Mayo Clinic advises inserting the 4-mm needle perpendicularly to the skin (at 90 degrees) for subcutaneous injections 18
For very young children (≤6 years) and very thin adults, the Mayo Clinic suggests lifting a skinfold and inserting the 4-mm needle perpendicularly into it 18
The Mayo Clinic recommends inspecting the injection site before administration and only giving injections into clean sites using clean hands 18
The Mayo Clinic advises against injecting into sites with lipohypertrophy, inflammation, edema, ulceration, infection, active impetigo, or herpes 18
Disinfection requirements are usually not required in noninstitutional settings, but mandatory in hospitals and nursing homes, according to the Mayo Clinic 18
If alcohol is used for disinfection, the Mayo Clinic recommends allowing it to dry completely before giving the injection 18

Intralesional Triamcinolone Acetonide: Evidence‑Based Guidelines

Dosing and Administration for Alopecia Areata

Use a concentration of 5–10 mg/mL injected just beneath the dermis in the upper subcutis for patients with alopecia areata. 19
Deliver 0.05–0.1 mL per injection site, which typically produces hair regrowth covering an area of roughly 0.5 cm in diameter. 19
Multiple injection sites may be treated in a single session; the primary limitation is patient discomfort rather than systemic toxicity. 19

Expected Efficacy in Alopecia Areata

Approximately 62 % of patients achieve a clinical response when injections are administered monthly.
Better outcomes are observed in individuals with fewer than five patches, each smaller than 3 cm in diameter. 19

Standard Injection Technique (Applicable to All Indications)

The needle should be placed just beneath the dermis in the upper subcutis; injection into deeper subcutaneous fat or the lesion itself is avoided. 19
Maintain the same 0.05–0.1 mL per site volume to achieve a localized effect while minimizing diffusion to surrounding tissue. 19

Safety Profile

Skin atrophy is the most consistently reported adverse effect, especially when higher concentrations of triamcinolone are used. 19

Availability in the Philippines

Intralesional triamcinolone acetonide is readily obtainable through dermatology clinics and major pharmaceutical distributors across the country. 19

Evidence Strength for Alopecia Areata

The British Journal of Dermatology (2003) assigns a Grade B recommendation to intralesional corticosteroids for alopecia areata, despite the underlying evidence being Grade III (limited controlled trials, largely based on clinical experience). 19